Abstract: An anchoring device for a cardiac valve is disclosed. The anchoring device includes a ventricular section (1), the ventricular section (1) includes an anchoring segment (11) and a capture segment (12), the anchoring segment (11) is in the form of a helical coil, a radius of curvature of the helical coil is constant and a distance between turns of the helical coil is the same, and the anchoring device does not include an atrial section. The anchoring device is made of an elastic material. The design of the anchoring device separating from the valve can provide an anchoring effect while allowing a delivery sheath of an associated delivery system to have a reduced radial dimension. During release of the anchoring device, the capture segment (12) can automatically capture the native leaflets or chordae tendineae. It is a modification of an existing anchor ring and dispenses with the use of a guide wire.

Abstract: Provided are modulators of androgen receptor (AR) condensates, methods of modulating or inhibiting AR condensates, and methods of treating diseases and conditions using such modulators or inhibitors of AR condensates.

Abstract: A driving circuit and a driving device for a display panel, and the driving circuit for the display panel includes: a stretching circuit, a control circuit, a bootstrapping circuit, and an output circuit; the control circuit is respectively electrically connected with the stretching circuit, the bootstrapping circuit, and the output circuit, and the bootstrapping circuit is electrically connected with the output circuit. The stretching signal generated by the stretching circuit can enable the bootstrapping circuit to have enough time to be charged, and ensure that the output circuit can reach or exceed the preset potential when receiving the bootstrap signal, thereby the voltage being not stable when the gate driving signal is output is avoided, and the phenomenon that the gate driving signal is stopped in advance is avoided.

Abstract: The present invention provides compounds of Formula I, pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.

Abstract: The present invention discloses a high step-down modular DC power supply, belonging to the field of power electronics technology, and the high step-down modular DC power supply includes an upper modular cascade circuit string, a lower modular cascade circuit string, a load, and an input source, where the upper modular cascade circuit string includes i upper sub-module circuits, and the lower modular cascade circuit string includes j lower sub-module circuits. A combination manner of module circuits includes: upper module string cascading, lower module string cascading, and hybrid cascading of the upper module string and the lower module string. The power supply is formed to be a high voltage step-down ratio power supply with high voltage direct current input and low voltage direct current output through modular cascading.

Abstract: A method includes: receiving, at a user equipment, a first information of a first gap for a first reference signal to be measured and a second information of a second gap for a second reference signal to be measured, wherein the first gap and the second gap overlap at least partially; and, determining at least one of: a first duration of a gap length based on a union of the first gap and the second gap, and a second duration of a gap length based on a selection of the first gap or the second gap corresponding to one of the first reference signal and the second reference signal.

Abstract: A paper lipstick tube with threads, including a lipstick tube body which includes an A lipstick tubing, a B lipstick tubing, a C lipstick tubing, a pin, a D lipstick tubing, an F lipstick tubing, an M lipstick tubing, a K lipstick tubing, a cover tube H, a circular gasket and cream. The B lipstick tubing is rotatably installed inside the F lipstick tubing. The lipstick tube body is a container with a push-pull function made of only paper and a small amount of natural bamboo or wood materials. Through mutual rotation of the F lipstick tubing and the B lipstick tubing, upward and downward shearing forces are applied to the pin spirally through the threaded groove in the B lipstick tubing. At the same time, the pin is also in up-and-down guide openings of the D lipstick tubing, so that the C lipstick tubing can only move up and down.

Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts and esters thereof: which inhibit the Apoptosis signal-regulating kinase 1 (ASK-1), which is associated with autoimmune disorders, neurodegenerative disorders, inflammatory diseases, chronic kidney disease, cardiovascular disease. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from ASK-1 related disease. The invention also relates to methods of treating an ASK-1 related disease in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The present invention specifically relates to methods of treating ASK-1 associated with hepatic steatosis, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

Abstract: A device for photo alignment includes: a bearing platform; a linearly polarized light source located at one side of the bearing platform; and a control assembly located between the linearly polarized light source and the bearing platform. One side of the bearing platform close to the control assembly is configured for placing a large plate glass to be aligned, and the large plate glass to be aligned includes a plurality of alignment areas; the linearly polarized light source is configured for providing a first polarized light to the control assembly; the control assembly is configured for adjusting a polarization direction of the first polarized light, and configured for providing a second polarized light to the plurality of alignment areas included in the large plate glass to be aligned; and polarization directions of the second polarized light respectively corresponding to at least two alignment areas are different.

Abstract: The present disclosure provides a method for preparing lithium iron phosphate from ferric hydroxyphosphate, including: purifying ferrous sulfate to form a ferrous sulfate solution, adding hydrogen peroxide, phosphoric acid, an ammonium dihydrogen phosphate solution and ammonia water into the ferrous sulfate solution and then reacting to form a mixed slurry, holding the mixed slurry at a temperature for a period of time, and then washing with water and subjecting to press filtration to form ferric hydroxyphosphate precursors with different iron-phosphorus ratios; then flash drying, sintering at a high temperature, and pulverizing to obtain ferric hydroxyphosphate precursors with different iron-phosphorus ratios and different specific surface areas.

Abstract: Certain aspects of the present disclosure provide techniques for controlling access and use of network resources and services by user equipment based on user equipment capabilities. In one aspect, a method for wireless communication by a network entity, includes: receiving, from a user equipment, a request to connect to a network, the request comprising a user equipment identifier and a reduced capability indication; determining a validity of the reduced capability indication based on at least one of: subscription data associated with the user equipment; or one or more capabilities associated with the user equipment; and making a connection decision based on the validity of the reduced capability indication.

Abstract: The present disclosure relates to methods and devices for wireless communication at an apparatus, e.g., a UE or a base station. The base station may be configured to configure one or more RACH resources for a FD RACH configuration and transmit, to at least one UE, an indication of the one or more RACH resources configured for the FD RACH configuration. The UE may be configured to receive the indication of the FD RACH configuration for the one or more RACH resources. The UE may further be configured to select, based on the received indication, at least one RACH resource of the one or more RACH resources for the FD RACH configuration and transmit, to the first base station via the selected at least one RACH resource, at least one message of a RACH procedure based on the FD RACH configuration.

Abstract: The present invention provides compounds represented by Formula I, or pharmaceutically acceptable salts, stereoisomers, solvates, hydrates or combination thereof, The invention also provides pharmaceutical compositions comprising these compounds and methods of using this compounds for treating FXR-mediated or TGR5-mediated diseases or conditions.

Abstract: A driving circuit and a driving device for a display panel, and the driving circuit for the display panel includes: a stretching circuit, a control circuit, a bootstrapping circuit, and an output circuit; the control circuit is respectively electrically connected with the stretching circuit, the bootstrapping circuit, and the output circuit, and the bootstrapping circuit is electrically connected with the output circuit. The stretching signal generated by the stretching circuit can enable the bootstrapping circuit to have enough time to be charged, and ensure that the output circuit can reach or exceed the preset potential when receiving the bootstrap signal, thereby the voltage being not stable when the gate driving signal is output is avoided, and the phenomenon that the gate driving signal is stopped in advance is avoided.

Abstract: Provided are a data processing system and method based on dynamic redundancy heterogeneous encoding, and a device. The method comprises: respectively performing error correction encoding on information to be processed and a processing rule, so as to form encoded information to be processed and an encoded processing rule; processing, by using the encoded processing rule, the encoded information to be processed, so as to obtain response data; and then performing error correction decoding on N pieces of response data, so as to obtain processing result information of the information to be processed.

Abstract: Disclosed are crystal form A and crystal form B of a compound represented by formula (I), and application thereof in the preparation of medicaments for treating HBV-related diseases.

Abstract: Example embodiments of the present disclosure relate to a solution for transmitting or receiving segments of information. In an aspect, a first device generates a plurality of messages to be transmitted to a second device. Each of the plurality of messages comprises a segment of information to be provided to the second device. The first device transmits a part of the plurality of messages to the second device. In response to the first device being triggered to perform an operation with a higher priority than the transmission of the plurality of messages, the first device performs the operation by interrupting the transmission of rest of the plurality of messages to be transmitted. With example embodiments of the present disclosure, it is enabled that transmission of messages conveying information segments may be interrupted to perform an operation with a higher priority.

Abstract: A method, device and computer readable medium for performing measurements in telecommunication systems are disclosed. The method comprises: includes receiving, from a first network device, a first configuration of a first measurement object for a carrier frequency; receiving, from a second network device, a second configuration of a second measurement object for the carrier frequency; determining an absolute time difference between a first measurement timing in the first configuration and a second measurement timing in the second configuration; and in response to determining that the absolute time difference is below a predetermined threshold, performing a single measurement for the carrier frequency based on the first measurement timing in the first configuration or the second measurement timing in the second configuration.

Abstract: In certain aspects, disclosed herein are methods of treating cancer in a subject, comprising administration to the subject of (1) one or more glucocorticoid receptor agonists and (2) one or more inhibitors of calcineurin. In some embodiments, the administration of the one or more glucocorticoid receptor agonists and the one or more inhibitors of calcineurin results in restoration of contact inhibition, increased formation of intercellular junctions, reduced cell proliferation, and/or increased vacuolization of cells growing in multilayer zones. Included herein are methods for identification of novel compounds that restore contact inhibition in cancer cells.